We offer a wide range of resources on complex issues that impact all people with chronic conditions. Resources include member-specific services, frequent meetings and events, publications, and comments on rules and legislation.
By: Marc Boutin, JD, Chief Executive Officer The National Health Council (NHC) acknowledges the complexity of the opioid crisis in the United States and commends
In today’s New York Times, Aaron Carrol writes about the use of comparative effectiveness research to ensure new drugs are safe and effective when compared
The National Health Council (NHC) has named Elisabeth Oehrlein, PhD, MS, as Senior Director, Research and Programs. In this newly created, leadership position, Dr. Oehrlein
By Marc Boutin, JD, NHC Chief Executive Officer Last week, the Centers for Medicare and Medicaid Services (CMS) issued a new policy touted as a
Today, FDA Commissioner, Scott Gottlieb, MD, spoke at our event, a dialogue on FDA’s first draft guidance on patient-focused drug development. Meeting participants engaged and
The National Health Council (NHC) is exploring how we communicate our work to members and to external audiences. For nearly 100 years, the NHC has
On July 31, the National Health Council (NHC) hosted an invitational dialogue on Patient-Centered Value Assessment. We gathered a group of patient advocates and experts
Today, the Trump Administration announced the final rule that allows the purchase of short-term health plans with incomplete coverage compared to insurance plans under the
The following statement is from NHC’s Chief Executive Officer, Marc Boutin, JD: The final short-term insurance plan rule is incredibly disappointing – especially in light